NTCOC
LGND icon

Northern Trust Company of Connecticut’s Ligand Pharmaceuticals LGND Stock Holding History

Northern Trust Company of Connecticut’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$5.14M Buy
+156,589
New +$5.1M 0.03% 679

Other funds holding LGND

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Northern Trust Company of Connecticut's LGND Position: Q4 2013 in Review

Northern Trust Company of Connecticut opened a new position in Ligand Pharmaceuticals (LGND) in Q4 2013: 156,589 shares worth $5.14M. The stake represents 0.03% of the portfolio and ranks #679 among its holdings.

165 funds tracked by Wall St. Rank hold LGND as of Q4 2013.

  • Northern Trust Company of Connecticut held 156,589 shares of Ligand Pharmaceuticals worth $5.14M as of Q4 2013.
  • Ligand Pharmaceuticals was a new Northern Trust Company of Connecticut position in Q4 2013.
  • Ligand Pharmaceuticals made up 0.03% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #679 holding.
  • 165 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.